Episode 820
Pfizer vaccine: an immunologist explains
Pfizer and BioNTech have concluded the Phase 3 trial of their coronavirus vaccine...
Naked Scientists, In Short Special Editions Podcast · The Naked Scientists
November 19, 20205m 54s
Audio is streamed directly from the publisher (flex.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Pfizer and BioNTech have concluded the Phase 3 trial of their coronavirus vaccine. The results appear to show an efficacy rate of 95%, and the developers hope to win FDA approval as soon as possible. This vaccine - a promising hope for many - works via a new methiod that's never been tried before in humans. Chris Smith asked Cambridge University immunologist Clare Bryant for her reaction... Like this podcast? Please help us by supporting the Naked Scientists
Topics
Clare Bryantpfizer vaccinecovidbioNTechcoronavirus vaccine